IL · ai · clinical trials · drug development
One round we have observed, with the investors the report named. Every figure below came from a named source, and where the company reported the raise to the SEC itself, that is shown beside it.
Series B · Aug 2026 · $45M
Qumra Capital lead, Accenture Ventures, Sanofi Ventures, Bertelsmann Healthcare Investments (BHI), Bertelsmann, GC Ventures, Artofin Venture Capital Fund L.P, Esplanade Ventures, NewHealth Ventures, Pitango HealthTech, Shoni Top Ventures
Reported by TechStartups and 1 other
Missing a round, or an investor who was in one? Tell us.